Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

Author:

Kowdley Kris V.1,Bowlus Christopher L.1,Levy Cynthia1,Akarca Ulus S.1,Alvares-da-Silva Mario Reis1,Andreone Pietro1,Arrese Marco1,Corpechot Christophe1,Francque Sven M.1ORCID,Heneghan Michael A.1,Invernizzi Pietro1,Jones David1,Kruger Frederik C.1,Lawitz Eric1,Mayo Marlyn J.1,Shiffman Mitchell L.1,Swain Mark G.1,Valera José Miguel1,Vargas Victor1,Vierling John M.1,Villamil Alejandra1,Addy Carol1,Dietrich Julie1,Germain Jean-Michel1,Mazain Sarah1,Rafailovic Dragutin1,Taddé Bachirou1,Miller Benjamin1,Shu Jianfen1,Zein Claudia O.1,Schattenberg Jörn M.1ORCID

Affiliation:

1. From Liver Institute Northwest, Seattle (K.V.K.); the Division of Gastroenterology and Hepatology, UC Davis School of Medicine, Sacramento (C.L.B.); Schiff Center for Liver Diseases, University of Miami, Miami (C.L.); the Department of Gastroenterology, Ege University Faculty of Medicine, İzmir, Turkey (U.S.A.); Gastroenterology and Hepatology Division, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil (M.R.A.-S.); Medicina Interna Metabolica,...

Funder

Ipsen

GENFIT

Publisher

Massachusetts Medical Society

Subject

General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3